Vitamin Shoppe Inc. (NYSE:VSI) shares gapped up prior to trading on Friday . The stock had previously closed at $30.69, but opened at $30.97. Vitamin Shoppe shares last traded at $31.64, with a volume of 69,414 shares changing hands.

VSI has been the topic of several recent analyst reports. Robert W. Baird reaffirmed a “hold” rating on shares of Vitamin Shoppe in a research note on Monday, May 16th. William Blair lowered Vitamin Shoppe to a “market perform” rating in a research note on Monday, March 28th. Jefferies Group reissued a “hold” rating and issued a $32.00 price objective (up previously from $30.00) on shares of Vitamin Shoppe in a research note on Friday, May 6th. Zacks Investment Research raised Vitamin Shoppe from a “hold” rating to a “buy” rating and set a $32.00 price objective on the stock in a research note on Tuesday, May 24th. Finally, Goldman Sachs Group Inc. lowered Vitamin Shoppe to a “hold” rating in a research note on Saturday, April 30th. One equities research analyst has rated the stock with a sell rating, ten have assigned a hold rating and two have issued a buy rating to the company. The company currently has a consensus rating of “Hold” and a consensus target price of $32.82.

The stock’s 50 day moving average is $30.37 and its 200-day moving average is $30.04. The firm has a market cap of $757.59 million and a PE ratio of 18.12.

Vitamin Shoppe (NYSE:VSI) last announced its earnings results on Wednesday, May 4th. The company reported $0.67 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.65 by $0.02. The company earned $336.80 million during the quarter, compared to analysts’ expectations of $339.76 million. During the same quarter last year, the firm posted $0.63 earnings per share. The firm’s revenue was up .0% on a year-over-year basis. Equities research analysts forecast that Vitamin Shoppe Inc. will post $2.32 EPS for the current fiscal year.

In other news, Director Guillermo Marmol bought 1,000 shares of the company’s stock in a transaction dated Tuesday, May 31st. The stock was bought at an average cost of $30.23 per share, for a total transaction of $30,230.00. Following the completion of the acquisition, the director now owns 1,470 shares in the company, valued at approximately $44,438.10. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link.

Other institutional investors have made changes to their positions in the company. California State Teachers Retirement System increased its position in shares of Vitamin Shoppe by 1.6% in the fourth quarter. California State Teachers Retirement System now owns 55,107 shares of the company’s stock worth $1,802,000 after buying an additional 885 shares in the last quarter. Tocqueville Asset Management L.P. increased its stake in shares of Vitamin Shoppe by 28.6% in the fourth quarter. Tocqueville Asset Management L.P. now owns 42,946 shares of the company’s stock valued at $1,404,000 after buying an additional 9,547 shares during the period. Rhumbline Advisers increased its stake in shares of Vitamin Shoppe by 4.3% in the fourth quarter. Rhumbline Advisers now owns 45,118 shares of the company’s stock valued at $1,475,000 after buying an additional 1,855 shares during the period. Barrow Hanley Mewhinney & Strauss LLC increased its stake in shares of Vitamin Shoppe by 8.8% in the fourth quarter. Barrow Hanley Mewhinney & Strauss LLC now owns 1,757,890 shares of the company’s stock valued at $57,483,000 after buying an additional 141,607 shares during the period. Finally, Gabelli Funds LLC increased its stake in shares of Vitamin Shoppe by 15.2% in the fourth quarter. Gabelli Funds LLC now owns 53,040 shares of the company’s stock valued at $1,734,000 after buying an additional 7,000 shares during the period.

Vitamin Shoppe, Inc (VSI) is a multi-channel specialty retailer and contract manufacturer of vitamins, minerals, herbs, specialty supplements, sports nutrition, and other health and wellness products. The Company operates through three segments: retail, which includes Vitamin Shoppe, Super Supplements and Vitapath retail store formats; direct, which sells its products directly to consumers through the Internet, primarily at www.vitaminshoppe.com, and manufacturing, which provides custom manufacturing and private labeling of vitamin, mineral and supplement (VMS) products.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.